EARLY MOVERS: Investors get a little hungrier for Papa John's stock; Amazon in focus after wage rises

Also before the New York bell, Clovis Oncology Inc shares were surging and Dunkin Donuts was gathering interest.

A look at what stories were piquing investor interest before the bell

There were a number of trending stores in the US before the Wall Street bell.

One of them concerned online retail behemoth Amazon.com Inc (NASDAQ:AMZN), whose shares shed 0.41% to stand at $1,996.

It comes as news emerged that the titan, which has now seemingly infiltrated into every corner of  our lives, had lifted the minimum wage for workers in the US  and the UK. 

It is being hailed as  major development for campaigners, which were pushing to try and put an end to the rising levels of poverty and inequality in both countries.

American workers will see minimum wage increase to $15 (£11.57) per hour, while in the UK, workers will see their pay rise to £10.50 in London and £9.50 across the rest of the country.

Elsewhere, in pre-market deals, Papa John's International Inc (NASDQ: PZZA), the pizza company, saw investors gain appetite for the shares, lifting them up over 3% in New York to $50.95.

It comes after it emerged Legion Partners, a stakeholder in the restaurant group, is talking to the company about how to turn around the sales decline at the group and resolve a dispute with the founder.

The activist fund also disclosed it now holds a 5.5% stake in the group.

Dunkin Donuts was also in the news on Tuesday, or rather its workers, and the company behind them - Dunkin Brands Group Inc (NASDAQ:DNKN)

The employees, who were involved in a viral video that shows one worker in a New York store dumping a pitcher of water on a homeless man while another person laughs, have been fired, it has emerged.

Shares in Dunkin added 0.33% to $73 before the bell in New York.

GE was also in the frame, climbing by 2.5% to $12.38. The jump in the struggling conglomerate's shares came as RBC Capital upgraded the stock to Outperform from Sector perform and lifted its price target to $15 per share from $13 after GE brought in Larry Culp as its new chairman and CEO.

Last but not least, Clovis Oncology Inc (NASDAQ:CLVS) saw shares add over 9% before the bell to $31.77 after the company's cancer drug Rubraca received what is called a "breakthrough therapy" designation from the key FDA (Food and Drug Administration).

-- updated with addition of GE news--



Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


CO2 GRO sees 20% higher pepper yields though 10 weeks of Hidroexpo Feasibility

CO2 GRO (CVE: GROW- OTCQB: BLONF) Vice President of Sales and Strategic Alliances Aaron Archibald joined Steve Darling from Proactive to bring details the company has seen very good results from their CO2 Delivery Solution commercial feasibility on greenhouse-grown peppers with Hidroexpo in...

2 days, 5 hours ago

2 min read